BioMérieux cuts 100 jobs

France's BioMerieux, a company that provides diagnostic solutions to help identify the source of disease, is laying off 100 workers at a plant in Portland, OR. The company is in the process of restructuring its culture media business in the U.S. and Canada and plans to phase out the Portland site starting next year. The company inherited the site when it acquired PML Microbiologicals two years ago.

Production of prepared media products at the Portland site will end in the middle of next year, with the plant closing its doors by the end of 2011. Manufacturing of other products will be transferred to another plant in Lombard, IL. In North America, the French company said it will focus on its "chromIDTM chromogenic culture media range that includes MRSA, Vancomycin-Resistant Enterococcus, and other high medical value tests. The company expects to save $3 million annually with the layoffs.

- check out BioMerieux's release

Suggested Articles

Takeda tapped Roche’s Foundation Medicine to develop tissue- and blood-based companion diagnostic tests for its portfolio of lung cancer therapies.

Cellex has announced plans to develop a rapid coronavirus test that people can fully perform at home, from sample collection to result, using an app.

More than 20 states either don’t release or have incomplete data on the rapid antigen tests now considered key to containing the coronavirus.